Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience

Clinical and patient reported outcomes of direct-acting antivirals for the treatment of chronic hepatitis C among patients in opioid agonist treatment: A real-world prospective cohort study

(2020) Bernd Schulte et al.   Open Forum Infectious Diseases

Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

(2020) Marion Mora et al.   JOURNAL OF VIRAL HEPATITIS

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review

(2020) Ida Sperle et al.   Frontiers in Public Health

HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

(2020) Colette Smit et al.   Lancet HIV

Response to direct acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy in Spain

(2019) Juan Macías et al.   JOURNAL OF HEPATOLOGY

Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy

(2019) Matthew J. Akiyama et al.   ANNALS OF INTERNAL MEDICINE

Patient-reported symptoms during and after direct acting antiviral therapies for chronic hepatitis C: The PROP UP Study

(2019) Donna M. Evon et al.   JOURNAL OF HEPATOLOGY

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐ SCOPE Study

(2019) Alain H. Litwin et al.   JOURNAL OF VIRAL HEPATITIS

Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice?

(2018) Stefan Christensen et al.   ADDICTION

‘Hep C’s like the common cold’: Understanding barriers along the HCV care continuum among young people who inject drugs

(2018) Margie R. Skeer et al.   DRUG AND ALCOHOL DEPENDENCE

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort

(2018) Carmine Rossi et al.   JOURNAL OF HEPATOLOGY

Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone

(2018) Andrew H Talal et al.   CLINICAL INFECTIOUS DISEASES

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

(2017) Louisa Degenhardt et al.   Lancet Global Health

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

(2016) Gregory J. Dore et al.   ANNALS OF INTERNAL MEDICINE

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

(2015) Bryony Simmons et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

(2013) Natasha K. Martin et al.   HEPATOLOGY

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance

(2010) Bernd Schulte et al.   DRUG AND ALCOHOL DEPENDENCE